Cargando…

Effectiveness of Calcium Phosphate Desensitising Agents in Dental Hypersensitivity Over 24 Weeks of Clinical Evaluation

Background: Calcium phosphate-based compounds are used to treat dental hypersensitivity (DH). Their long-term clinical behaviour needs further research. This study compared the 24-week effectiveness of Teethmate Desensitizer (TD), a pure tetracalcium phosphate (TTCP) and dicalcium phosphate dihydrat...

Descripción completa

Detalles Bibliográficos
Autores principales: Usai, Paolo, Campanella, Vincenzo, Sotgiu, Giovanni, Spano, Giovanni, Pinna, Roberto, Eramo, Stefano, Saderi, Laura, Garcia-Godoy, Franklin, Derchi, Giacomo, Mastandrea, Giorgio, Milia, Egle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955887/
https://www.ncbi.nlm.nih.gov/pubmed/31818019
http://dx.doi.org/10.3390/nano9121748
_version_ 1783487032458215424
author Usai, Paolo
Campanella, Vincenzo
Sotgiu, Giovanni
Spano, Giovanni
Pinna, Roberto
Eramo, Stefano
Saderi, Laura
Garcia-Godoy, Franklin
Derchi, Giacomo
Mastandrea, Giorgio
Milia, Egle
author_facet Usai, Paolo
Campanella, Vincenzo
Sotgiu, Giovanni
Spano, Giovanni
Pinna, Roberto
Eramo, Stefano
Saderi, Laura
Garcia-Godoy, Franklin
Derchi, Giacomo
Mastandrea, Giorgio
Milia, Egle
author_sort Usai, Paolo
collection PubMed
description Background: Calcium phosphate-based compounds are used to treat dental hypersensitivity (DH). Their long-term clinical behaviour needs further research. This study compared the 24-week effectiveness of Teethmate Desensitizer (TD), a pure tetracalcium phosphate (TTCP) and dicalcium phosphate dihydrate (DCPD) powder/water, to that of Dentin Desensitizer (DD), and Bite & White ExSense (BWE), both of calcium phosphate crystallites. Methods: A total of 105 subjects were selected. A random table was utilised to form three groups of 35 subjects. DH was evaluated using the evaporative sensitivity, tactile sensitivity tests, and the visual analogue scale (VAS) of pain. Response was recorded before the application of the materials (Pre-1), immediately after (Post-0), at 1 week (Post-1), 4 weeks (Post-2), 12 weeks (Post-3) and 24 weeks (Post-4). The non-parametric distribution was assessed with the Shapiro–Wilk statistical test. Intra-group differences for the six time points were evaluated with the Friedman statistical test and the Kruskal–Wallis test. Results: All the materials decreased DH after 24 weeks in comparison to Pre-1. However, the TTCP/DCPD cement showed the greatest statistical efficiency. Conclusions: The significant decrease of VAS scores produced by TD in the long term suggest the material as the most reliable in the clinical relief of DH.
format Online
Article
Text
id pubmed-6955887
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-69558872020-01-23 Effectiveness of Calcium Phosphate Desensitising Agents in Dental Hypersensitivity Over 24 Weeks of Clinical Evaluation Usai, Paolo Campanella, Vincenzo Sotgiu, Giovanni Spano, Giovanni Pinna, Roberto Eramo, Stefano Saderi, Laura Garcia-Godoy, Franklin Derchi, Giacomo Mastandrea, Giorgio Milia, Egle Nanomaterials (Basel) Article Background: Calcium phosphate-based compounds are used to treat dental hypersensitivity (DH). Their long-term clinical behaviour needs further research. This study compared the 24-week effectiveness of Teethmate Desensitizer (TD), a pure tetracalcium phosphate (TTCP) and dicalcium phosphate dihydrate (DCPD) powder/water, to that of Dentin Desensitizer (DD), and Bite & White ExSense (BWE), both of calcium phosphate crystallites. Methods: A total of 105 subjects were selected. A random table was utilised to form three groups of 35 subjects. DH was evaluated using the evaporative sensitivity, tactile sensitivity tests, and the visual analogue scale (VAS) of pain. Response was recorded before the application of the materials (Pre-1), immediately after (Post-0), at 1 week (Post-1), 4 weeks (Post-2), 12 weeks (Post-3) and 24 weeks (Post-4). The non-parametric distribution was assessed with the Shapiro–Wilk statistical test. Intra-group differences for the six time points were evaluated with the Friedman statistical test and the Kruskal–Wallis test. Results: All the materials decreased DH after 24 weeks in comparison to Pre-1. However, the TTCP/DCPD cement showed the greatest statistical efficiency. Conclusions: The significant decrease of VAS scores produced by TD in the long term suggest the material as the most reliable in the clinical relief of DH. MDPI 2019-12-09 /pmc/articles/PMC6955887/ /pubmed/31818019 http://dx.doi.org/10.3390/nano9121748 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Usai, Paolo
Campanella, Vincenzo
Sotgiu, Giovanni
Spano, Giovanni
Pinna, Roberto
Eramo, Stefano
Saderi, Laura
Garcia-Godoy, Franklin
Derchi, Giacomo
Mastandrea, Giorgio
Milia, Egle
Effectiveness of Calcium Phosphate Desensitising Agents in Dental Hypersensitivity Over 24 Weeks of Clinical Evaluation
title Effectiveness of Calcium Phosphate Desensitising Agents in Dental Hypersensitivity Over 24 Weeks of Clinical Evaluation
title_full Effectiveness of Calcium Phosphate Desensitising Agents in Dental Hypersensitivity Over 24 Weeks of Clinical Evaluation
title_fullStr Effectiveness of Calcium Phosphate Desensitising Agents in Dental Hypersensitivity Over 24 Weeks of Clinical Evaluation
title_full_unstemmed Effectiveness of Calcium Phosphate Desensitising Agents in Dental Hypersensitivity Over 24 Weeks of Clinical Evaluation
title_short Effectiveness of Calcium Phosphate Desensitising Agents in Dental Hypersensitivity Over 24 Weeks of Clinical Evaluation
title_sort effectiveness of calcium phosphate desensitising agents in dental hypersensitivity over 24 weeks of clinical evaluation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955887/
https://www.ncbi.nlm.nih.gov/pubmed/31818019
http://dx.doi.org/10.3390/nano9121748
work_keys_str_mv AT usaipaolo effectivenessofcalciumphosphatedesensitisingagentsindentalhypersensitivityover24weeksofclinicalevaluation
AT campanellavincenzo effectivenessofcalciumphosphatedesensitisingagentsindentalhypersensitivityover24weeksofclinicalevaluation
AT sotgiugiovanni effectivenessofcalciumphosphatedesensitisingagentsindentalhypersensitivityover24weeksofclinicalevaluation
AT spanogiovanni effectivenessofcalciumphosphatedesensitisingagentsindentalhypersensitivityover24weeksofclinicalevaluation
AT pinnaroberto effectivenessofcalciumphosphatedesensitisingagentsindentalhypersensitivityover24weeksofclinicalevaluation
AT eramostefano effectivenessofcalciumphosphatedesensitisingagentsindentalhypersensitivityover24weeksofclinicalevaluation
AT saderilaura effectivenessofcalciumphosphatedesensitisingagentsindentalhypersensitivityover24weeksofclinicalevaluation
AT garciagodoyfranklin effectivenessofcalciumphosphatedesensitisingagentsindentalhypersensitivityover24weeksofclinicalevaluation
AT derchigiacomo effectivenessofcalciumphosphatedesensitisingagentsindentalhypersensitivityover24weeksofclinicalevaluation
AT mastandreagiorgio effectivenessofcalciumphosphatedesensitisingagentsindentalhypersensitivityover24weeksofclinicalevaluation
AT miliaegle effectivenessofcalciumphosphatedesensitisingagentsindentalhypersensitivityover24weeksofclinicalevaluation